United States, Oct. 14 -- United States based CIDARA THERAPEUTICS INC has secured contract from Health And Human Services, Department Of for Development Of Cd388 As A Long-Lasting Prophylactic Anti-Viral Option For Protection Against The Health Impacts Caused By Influenza. The value of the contract is worth 339189481 USD.
Published by HT Digital Content Services with permission from Pivotal Sources....